Fernández-Palazzi F, Viso R, Boadas A, Ruiz-Sáez A, Caviglia H, De Bosch N Blumenfeld
Unidad de Ortopedia del Centro Nacional de Hemofilia, Banco de Sangre del DC Caracas, Venezuela.
Haemophilia. 2002 May;8(3):375-81. doi: 10.1046/j.1365-2516.2002.00627.x.
We report our preliminary experience with the use of hyaluronic acid (Synvisc) in 29 joints from 25 different haemophilic patients (17 knees, six shoulders, four ankles, one elbow and one hip). All the joints were grade III of our classification, characterized by synovial thickening, axial deformities and muscle atrophy (chronic arthropathy). In view of the very satisfactory results obtained with this procedure, we have substituted Synvisc for the previous use of intra-articular long-standing corticosteroids that we had been used for some years. This method is theoretically more physiological and does not destroy the joint cartilage further, as corticosteroids can.
我们报告了在25名不同血友病患者的29个关节中使用透明质酸(施沛特)的初步经验(17个膝关节、6个肩关节、4个踝关节、1个肘关节和1个髋关节)。所有关节均为我们分类中的III级,其特征为滑膜增厚、轴向畸形和肌肉萎缩(慢性关节病)。鉴于该方法取得了非常令人满意的结果,我们已用施沛特替代了过去多年一直使用的关节内长效皮质类固醇。从理论上讲,这种方法更符合生理,不会像皮质类固醇那样进一步破坏关节软骨。